Novavax Share Price Reaches New All-Time High
December 16, 2013 at 15:18 PM EST
Shares of Novavax (NASDAQ: NVAX ) reach 52-week high at $4.46, up 15.245% following Wedbush analyst Gregory Wade significantly raised the price target from $4 to $12. Wade noted higher revised expectations on the RSV/ flu combo product format. The analyst noted that Wedbush's model predicts that sales
